The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.
about
The long-term outcomes of interventions for the management of attention-deficit hyperactivity disorder in children and adolescents: a systematic review of randomized controlled trialsPhysical activity for improving the symptoms of attention deficit hyperactivity disorder in children and adolescentsOptimal management of ADHD in older adultsIs Adult Attention-Deficit Hyperactivity Disorder Being Overdiagnosed?A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populationsCost-effectiveness of extended-release methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder sub-optimally treated with immediate release methylphenidateInitiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in TaiwanLatest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistenceAn inventory of European data sources for the long-term safety evaluation of methylphenidateUtilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence.Implementation of independent nurse prescribing in UK mental health settings: focus on attention-deficit/hyperactivity disorder.Adult ADHD patient experiences of impairment, service provision and clinical management in England: a qualitative study.Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancyEpidemiology of treated attention-deficit/hyperactivity disorder (ADHD) across the lifespan in Taiwan: a nationwide population-based longitudinal study.South African foundation phase teachers' perceptions of ADHD at private and public schools.Prevalence and incidence of attention-deficit/hyperactivity disorder in Slovenian children and adolescents: a database study from a national perspectiveBeing Small for Gestational Age: Does it Matter for the Neurodevelopment of Premature Infants? A Cohort Study.Experiences of adolescents and young adults with ADHD in Hong Kong: treatment services and clinical management.Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study.Recommendations for the transition of patients with ADHD from child to adult healthcare services: a consensus statement from the UK adult ADHD network.Temporal Trends in the Prevalence and Incidence of Diagnosed ADHD in Children and Young Adults between 1999 and 2012 in Canada: A Data Linkage Study.Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners.ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis.Pediatric psychopharmacology: Too much and too little.Increasing use of prescription drugs in the United Kingdom.Diagnostic efficiency of the SDQ for parents to identify ADHD in the UK: a ROC analysisUnderstanding the treatment of attention deficit hyperactivity disorder in newly diagnosed adult patients in general practice: a UK database studyUse of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorderPrescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011.Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system.Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study.Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan.Effect of attention-deficit-hyperactivity-disorder training program on the knowledge and attitudes of primary school teachers in Kaduna, North West Nigeria.ADHD in Germany: Trends in Diagnosis and Pharmacotherapy.Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology.
P2860
Q22241444-FB85C2CB-2E12-49C3-9FFB-87FEBE51128FQ24186079-084021FF-6B9F-4C5B-A351-CF07E343B327Q26774425-EA520BB2-B726-4679-8B91-D92C522A0BFFQ26801761-AF6071AD-ED15-4A78-9024-4650FEB7442FQ26849359-F329B5AB-BACC-4CA0-A986-174DF79AB433Q28547634-2F3C6EE7-0A1E-4F7B-928B-31E1D141D5CEQ28553475-9EBD999E-5BB0-4141-B8D0-1C49EECF87A5Q28596811-2BA243F0-844D-4569-9805-A76D1A529845Q30603225-496D6514-04D4-4B8A-8183-0901936B81E9Q31146596-1352E8A4-155E-401F-9984-C3AA5307BF26Q33165620-290196E0-1FB6-4DBA-A4DB-3947ABAA5879Q34394522-6DB33C7A-F709-4760-AAC1-25F97344AE27Q34502493-F101C274-3120-4FC4-B7DC-825622721B82Q34567343-DEB4C245-8FD5-4A80-BFAB-4F90980236A7Q34732808-FCAB8A27-ADDF-4C76-BBFB-80EAC0A73AC5Q35049056-BEB554C6-547B-47D6-99D6-6D5DD2AB86B9Q35149061-4FF1AC40-A014-4ADE-8CD8-9C447FBC5129Q35228100-AA57E238-AE1C-4C88-B375-5D3E11F8B018Q35539548-5F4C92B8-7BF2-4AB1-BF48-13AE88AFF9BEQ35597899-CE3B17F2-F88C-47CE-9A55-0FC6DB9C4D4AQ35618988-05316D20-ECA3-4B66-8ED4-7C940D5D6D8CQ35769693-61DED9C6-DFFF-45C3-9E26-AF45C4CDD297Q36113283-D84A0DA2-C6B5-4FF5-9775-CD2AA8763466Q36406035-CFE4546A-9452-4978-8699-B71B72A30A9FQ36687941-68F21F08-50BA-4B78-BFC6-22096B2BFAD4Q36756237-A47D273A-B360-4C88-8E64-141267253219Q36930852-84D8A2E8-3991-4882-9F4C-67238E1AB762Q36957932-18CAAB77-9A73-4431-AC26-F5F5C23C4DA9Q37188240-6DF76C6B-64C6-4F2F-B8FD-0B9438A2500BQ37300928-F6ABAEAE-D24C-4B3C-B7C5-CD40110BEED3Q37416392-36C8DF5A-9F0B-4D82-8A29-B274EB1F23F1Q37472334-9D6A61E6-FA40-4EE7-9C97-75990D19949BQ37525872-A2BDEEF7-E5E5-499D-9CBE-8D3F2BFF9E56Q37598430-3C3A9A1C-CA06-49FD-B3B3-733DFCF229F1Q37648289-7E1A5E82-28F8-4FFF-9909-5C8C619AEFDDQ37663632-D6254FC2-1B18-4D37-8613-78DC37F18E88Q37682858-100EF373-04E4-4626-A54D-9AD792604E0AQ37713315-209A96E1-1763-410A-8FFB-462C78CD83ADQ37736303-25567FA6-AFFC-48A7-86A8-62D5B06890F6Q38187892-03EAAFF1-E4AE-4286-B5B3-458AA1324207
P2860
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The epidemiology of pharmacolo ...... and adults in UK primary care.
@ast
The epidemiology of pharmacolo ...... and adults in UK primary care.
@en
The epidemiology of pharmacolo ...... and adults in UK primary care.
@nl
type
label
The epidemiology of pharmacolo ...... and adults in UK primary care.
@ast
The epidemiology of pharmacolo ...... and adults in UK primary care.
@en
The epidemiology of pharmacolo ...... and adults in UK primary care.
@nl
prefLabel
The epidemiology of pharmacolo ...... and adults in UK primary care.
@ast
The epidemiology of pharmacolo ...... and adults in UK primary care.
@en
The epidemiology of pharmacolo ...... and adults in UK primary care.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
The epidemiology of pharmacolo ...... and adults in UK primary care.
@en
P2093
Lynda Wilton
Paul Hodgkins
Suzanne McCarthy
P2860
P2888
P356
10.1186/1471-2431-12-78
P577
2012-06-19T00:00:00Z
P5875
P6179
1007687106